Basic research on virus-induced asthma exacerbation: Inhibition of inflammatory chemokine expression by fluticasone propionate

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 84-92

  Matsukura, Satoshi ^a   Kurokawa, Masatsugu ^a   Homma, Tetsuya ^a   Watanabe, Shin ^a   Suzuki, Shintaro ^a   Ieki, Koushi ^a   Takeuchi, Hiroko ^a   Notomi, Kyoko ^a   Schleimer, Robert P ^d   Kawaguchi, Mio ^b   Kokubu, Fumio ^c  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Airway epithelial cells; Glucocorticoids; Inflammatory chemokines; Virus induced asthma

Indexed keywords

DACTINOMYCIN; DOUBLE STRANDED RNA; FLUTICASONE PROPIONATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 8; MESSENGER RNA; RANTES; ANDROSTANE DERIVATIVE; ANTIALLERGIC AGENT; AUTACOID; CHEMOKINE; FLUTICASONE; HISTONE ACETYLTRANSFERASE; POLYINOSINIC POLYCYTIDYLIC ACID; TRANSCRIPTION FACTOR;

ADENOVIRUS 12; ASTHMA; CELL NUCLEUS; COLORIMETRY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; INCUBATION TIME; LUCIFERASE ASSAY; LUNG ALVEOLUS EPITHELIUM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VIRUS INDUCED ASTHMA; WESTERN BLOTTING; ARTICLE; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN TRANSPORT; RNA STABILITY; TRANSCRIPTION INITIATION; VIROLOGY;

ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ASTHMA; CELL LINE; CELL NUCLEUS; CHEMOKINE CCL5; CHEMOKINES; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HUMANS; INFLAMMATION MEDIATORS; POLY I-C; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

MLCS; MLOWN;

EID: 84880555229     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350455     Document Type: Conference Paper

References (23)

1. Kim WK, Gern JE: Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol Res 2012; 4:116-121.
2. Singanayagam A, Joshi PV, Mallia P, Johnston SL: Viruses exacerbating chronic pulmonary disease: the role of immune modulation. BMC Med 2012; 10:27.
3. Matsukura S, Kokubu F, Kubo H, Tomita T, Tokunaga H, Kadokura M, Yamamoto T, Ku-roiwa Y, Ohno T, Suzaki H, Adachi M: Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 1998; 18:255-264.
4. Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M: Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996; 98:1080-1087.
5. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M: Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005; 280:5571-5580.
6. Slater L, Bartlett NW, Haas JJ, Zhu J, Message SD, Walton RP, Sykes A, Dahdaleh S, Clarke DL, Belvisi MG, Kon OM, Fujita T, Jeffery PK, Johnston SL, Edwards MR: Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010; 6:e1001178.
7. Rudd BD, Burstein E, Duckett CS, Li X, Lu-kacs NW: Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 2005; 79:3350-3357.
8. Ieki K, Matsukura S, Kokubu F, Kimura T, Kuga H, Kawaguchi M, Odaka M, Suzuki S, Watanabe S, Takeuchi H, Schleimer RP, Adachi M: Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and inter-feron regulatory factors in human airway epithelial cells. Clin Exp Allergy 2004; 34: 745-752.
9. Matsukura S, Kokubu F, Kurokawa M, Kawaguchi M, Ieki K, Kuga H, Odaka M, Suzuki S, Watanabe S, Takeuchi H, Kasama T, Adachi M: Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Clin Exp Allergy 2006; 36:1049-1062.
10. Torres D, Dieudonne A, Ryffel B, Vilain E, Si-Tahar M, Pichavant M, Lassalle P, Trottein F, Gosset P: Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells. J Immunol 2010; 185:451-459.
11. Barnes PJ: Glucocorticosteroids: current and future directions. Br J Pharmacol 2011; 163: 29-43.
12. Skevaki CL, Christodoulou I, Spyridaki IS, Ti-niakou I, Georgiou V, Xepapadaki P, Kafetzis DA, Papadopoulos NG: Budesonide and for-moterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin Exp Allergy 2009; 39: 1700-1710.
13. Edwards MR, Johnson MW, Johnston SL: Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006; 34:616-624.
14. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, Georas SN, Casolaro V, Schleimer RP: Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 1999; 163:6876-6883.
15. Homma T, Matsukura S, Hirose T, Ohnishi T, Kimura T, Kurokawa M, Ieki K, Odaka M, Suzuki S, Watanabe S, Sato M, Kawaguchi M, Schleimer RP, Adachi M: Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferon-gamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells. Int Arch Allergy Immunol 2010; 152(suppl 1):9-17.
16. Stellato C: Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets. J Allergy Clin Immunol 2007; 120:1247-1263.
17. McCoy CE, Carpenter S, Pålsson-McDermott EM, Gearing LJ, O'Neill LA: Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and-4 by targeting TBK1 activation. J Biol Chem 2008;283: 14277-14285.
18. Hara Y, Shiraishi A, Kobayashi T, Kadota Y, Shirakata Y, Hashimoto K, Ohashi Y: Alteration of TLR3 pathways by glucocorticoids may be responsible for immunosusceptibility of human corneal epithelial cells to viral infections. Mol Vis 2009; 15:937-948.
19. O'Neill LA: When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 2008; 29:12-20.
20. Kino T, Slobodskaya O, Pavlakis GN, Chrou-sos GP: Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 2002; 277:2396-2405.
21. Dobrovolna J, Chinenov Y, Kennedy MA, Liu B, Rogatsky I: Glucocorticoid-dependent phosphorylation of the transcriptional coreg-ulator GRIP1. Mol Cell Biol 2012; 32:730-739.
22. Grunberg K, Sharon RF, Sont JK, In 't Veen JC, Van Schadewijk WA, De Klerk EP, Dick CR, Van Krieken JH, Sterk PJ: Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001; 164:1816-1822.
23. Davies JM, Carroll ML, Li H, Poh AM, Kirke-gard D, Towers M, Upham JW: Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One 2011; 6:e27898.